SYNTHETIC APOLIPOPROTEIN – A NOVEL CLINICAL AGENT

Groundbreaking studies suggest that APO, a precisely created version of APO, presents a hopeful medicinal approach for treating multiple illness circumstances. This cutting-edge agent operates by specifically altering lipid metabolism and reducing swelling, showing notable benefit in preclinical